suMMARY In a prospective double blind randomised study in 25 consecutive patients a conventional ionic contrast medium (Urografin 370) was compared with the new non-ionic medium iohexol 350 (Omnipaque) in left ventriculography and coronary arteriography. In left ventriculography there was a clear patient preference for iohexol by both a visual analogue scale and independent observer assessment. Iohexol also induced a smaller increase in heart rate or decrease in systolic blood pressure than Urografin. In coronary arteriography iohexol resulted in a smaller reduction in heart rate and systolic blood pressure, a smaller maximum increase in RR interval, less prolongation of the PQ and QT intervals and QRS duration, and a lower incidence of induced chest pain, ST segment depression, or T wave deflection.
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Left ventriculography and coronary arteriography in patients investigated because of suspected coronary artery disease carry a low morbidity and very low mortality risk.' The left ventriculogram in most patients produces pain and heat sensation of a variable degree. The severity of the discomfort appears to be related to the degree of induced arteriolar dilatation, both of which are related to the osmolality of the contrast medium used,2 although their precise interrelation remains uncertain. The impairment of myocardial contractility which occurs after selective coronary arteriography is directly related to the osmolality and the chemistry of the contrast medium used, as are the electrocardiographic changes seen as a result of direct inhibition of sinoatrial node automaticity and atrioventricular nodal conductivity and conduction delay in distal portions of the Purkinje network. 3 The first non-ionic and low osmolality contrast medium metrizamide (Amipaque) was produced as long ago as 1972. Clinical studies showed that it was associated with less patient discomfort after left ventriculography4 and with fewer T wave abnormalities4 and less chest pain5 after coronary arteriography when compared with ionic contrast media. Its major drawRequests for reprints to Dr E Sowton, Department of Cardiology, Guy's Hospital, London SEI 9RT.
Accepted for publication 12 January 1984 backs, however, were its instability in aqueous solution and its very high cost. More recently, stable solutions of three different low osmolality contrast media have been developed. The ionic mono-acid dimer Hexabrix (Guerbet) was found to be associated with less patient discomfort during left ventriculography than the conventional ionic contrast media but with similar T wave changes during coronary arteriography when compared with Urografin 370 and with more T wave changes than Triosil or metrizamide.6 The nonionic compound iopamidol-(Niopam, E Merck Ltd) achieved greater patient tolerance and a significantly smaller increase in peripheral arterial blood flow than a conventional ionic contrast medium in lumbar aortography.7 Its use in a non-randomised open study has also shown less patient discomfort after left ventriculography, a smaller decrease in systolic blood pressure and heart rate, and fewer T wave electrocardiographic changes after selective coronary arteriography.5 
VENTRICULOGRAPHY
Patients were warned to expect a "warm feeling" after left ventriculography and that they would be asked subsequently to assess this sensation. After the second left ventricular angiogram subjective patient responses to each were graded on as: 0, no discomfort; 1, mild heat or pain; 2, moderate heat or pain; 3, distress or nausea or both; and 4, vomiting or retching or both. Each patient was then asked to grade "discomfort" associated with each of the left ventricular angiograms on a 0 (no discomfort) to 100 (intolerable discomfort) visual analogue scale. Heart rate, systolic blood pressure, and left ventricular end diastolic pressure were measured before each left ventricular angiogram and immediately, one, two, and three minutes after. There was a delay of 10-15 s in obtaining the "immediate" recordings while the catheter was flushed with saline and reconnected to the manometer line. Heart rate was calculated from the mean of 10 consecutive cycle lengths and left ventricular end diastolic and systolic pressures from the mean of five consecutive cycle lengths. Left ventricular end diastolic pressure was measured after the "a" wave, all 25 patients being in sinus rhythm. for iohexol and 5.7+4.0 for Urografin. There were greater numbers of patients with chest pain, ST segTwenty two patients had coronary artery disease; ment depression, or T wave deflection induced by three (two men, one woman) had angiographically selective coronary artery injections of Urografin than normal coronary arteries. One of the latter, the of iohexol, although the difference was statistically youngest patient in the series, had hypertrophic car-significant only in the latter (Table 3) . Reductions in diomyopathy.
heart rate and systolic blood pressure, each measured When the paired and matching left ventricular as mean values of 10 cycles before and immediately angiograms were reviewed no difference in image after coronary injections, and maximum increase in quality could be detected. The iodine concentration of RR intervals were all greater with Urografin than with the iohexol (350 mg/ml) was slightly lower than that of iohexol, the differences being highly significant after the Urografin (370 mg/ml). left coronary arteriography (Table 4 ). There was a clear patient preference for iohexol in There were also major differences in induced conleft ventriculography, as judged by the patients' own duction changes between the two media. The QT and Table 2 Increases in left ventricular end diastolic pressure, systolic blood pressure, and heart rate expressed as mean percentage increase (-+SD) ofvalues before ventriculography, induced up to 3 minutes after left ventriculography using iohexol or Urografin PQ intervals and QRS duration after left coronary arteriography and the QT and PQ intervals after right coronary injections were significantly more prolonged with Urografin than with iohexol ( Table 4 ). The differences in the degree of prolongation of the QT interval were most pronounced.
Discussion
The haemodynamic and electrocardiographic findings during coronary arteriography are in keeping with reports that impairment of myocardial contractility and induced conduction tissue abnormalities are largely dependent on the hyperosmolality of the contrast medium.3 Studies with iohexol in dogs9 10 have reported similar findings.
A definite patient preference for left ventriculography using lower osmolality contrast media of both ionic6 and non-ionic8 composition has previously been shown. In addition, the present study indicates that there is less alteration of the resting haemodynamic state with a non-ionic contrast medium.
The clinical significance of the electrocardiographic changes induced by coronary arteriography is imprecise. In particular, there has been no definite correlation between any of the observed changes in the electrocardiogram and the induction of ventricular fibrillation.3 A relation between the degree of prolongation of the QT interval and the likelihood of ventricular fibrillation has, however, been noted in dog coronary arteriography,"I both of which occurred significantly less frequently with a non-ionic low osmolality contrast medium. The occurrence of serious ventricular arrhythmias in patients with long QT intervals is well known clinically. The greater increase in QT interval, however, occurred in this study after left rather than right coronary artery injections. Ventricular fibrillation during clinical coronary arteriography is reported to occur more frequently after selective right, rather than left, coronary artery injections,'2 which suggests that prolongation of the QT interval may not be the most important factor in its genesis.
A theoretical disadvantage of the low osmolality contrast media in coronary arteriography may be a smaller increase in coronary blood flow compared with that with conventional contrast media owing to the less pronounced vasodilatory effect. This increased flow has been thought to minimise the time the contrast medium is in the coronary circulation,3
and an increased coronary transit time has been reported for metrizamide compared with that for conventional ionic media in man.5 Coronary transit time was measured from the cine film as the time from the start of the contrast medium injection into the left coronary artery until the appearance of contrast medium in the first part of the coronary sinus. A study in dogs, however, showed that metrizamide was cleared more rapidly both from the coronary arteries and from the coronary sinus than a conventional ionic contrast medium despite producing a smaller increase in coronary flow.'3 One possible explanation is slower clearance of the highly deformed erythrocytes which result from exposure to the hyperosmolar medium and which are less easily able to pass through capillaries.
Another potential benefit of these new contrast media may be a reduction in "allergic" or hypersensitivity reactions. Both iopamidol and iohexol have been shown to induce significantly less bronchospasm than an ionic medium of higher osmolality when injected intravenously. '4 In this study iohexol was clearly preferred to Urografin by patients undergoing left ventriculography and induced fewer haemodynamic and electrocardiographic changes during coronary arteriography. Most of the patients experienced only mild or moderate discomfort after left ventriculography with Urografin, although the total volume and rate of injection of contrast medium used for each left ventriculogram were less than those routinely used in Comparative trial of iohexol 350 many other centres. The electrocardiographic and haemodynamic changes seen after coronary arteriography using the same agent did not induce arrhythmias or other complications in any patient, which is in keeping with common clinical experience. Hence, it is possible that the routine use of the more expensive lower osmolality media may not be currently justified in every patient undergoing left ventriculography and coronary arteriography but may be indicated in selected patients such as those with compromised haemodynamic states, unstable angina, acute myocardial infarction, history of allergy or previous adverse reaction to contrast medium, impaired renai function, and those undergoing transluminal coronary angioplasty or receiving large volumes of contrast medium. 
